These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37158739)

  • 1. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
    Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
    Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kreutzfeld O; Orena S; Okitwi M; Tumwebaze PK; Byaruhanga O; Katairo T; Conrad MD; Legac J; Garg S; Crudale R; Aydemir O; Giesbrecht D; Nsobya SL; Blasco B; Duffey M; Rouillier M; Bailey JA; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0046624. PubMed ID: 39136468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum Isolates.
    Kreutzfeld O; Rasmussen SA; Ramanathan AA; Tumwebaze PK; Byaruhanga O; Katairo T; Asua V; Okitwi M; Orena S; Legac J; Conrad MD; Nsobya SL; Aydemir O; Bailey J; Duffey M; Bayles BR; Vaidya AB; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0077121. PubMed ID: 34339273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors.
    Garg S; Kreutzfeld O; Chelebieva S; Tumwebaze PK; Byaruhanga O; Okitwi M; Orena S; Katairo T; Nsobya SL; Conrad MD; Aydemir O; Legac J; Gould AE; Bayles BR; Bailey JA; Duffey M; Lin G; Kirkman LA; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0081722. PubMed ID: 36094216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates.
    Foguim FT; Bogreau H; Gendrot M; Mosnier J; Fonta I; Benoit N; Amalvict R; Madamet M; Wein S; Pradines B;
    Malar J; 2020 Jun; 19(1):201. PubMed ID: 32503540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug susceptibility of
    Tumwebaze PK; Katairo T; Okitwi M; Byaruhanga O; Orena S; Asua V; Duvalsaint M; Legac J; Chelebieva S; Ceja FG; Rasmussen SA; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Bayles BR; Rosenthal PJ; Cooper RA
    Lancet Microbe; 2021 Sep; 2(9):e441-e449. PubMed ID: 34553183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates.
    Kreutzfeld O; Tumwebaze PK; Byaruhanga O; Katairo T; Okitwi M; Orena S; Rasmussen SA; Legac J; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Duffey M; Cooper RA; Rosenthal PJ
    J Infect Dis; 2022 Feb; 225(4):696-704. PubMed ID: 34460932
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Somé AF; Conrad MD; Kabré Z; Fofana A; Yerbanga RS; Bazié T; Neya C; Somé M; Kagambega TJ; Legac J; Garg S; Bailey JA; Ouédraogo J-B; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0153423. PubMed ID: 38411062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Short-Term Storage on
    Okitwi M; Orena S; Thomas K; Tumwebaze PK; Byaruhanga O; Nsobya SL; Conrad MD; Bayles BR; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0143721. PubMed ID: 35266828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing Antimalarial Drug Sensitivities in Uganda.
    Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
    Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
    BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker.
    Leroy D; Macintyre F; Adoke Y; Ouoba S; Barry A; Mombo-Ngoma G; Ndong Ngomo JM; Varo R; Dossou Y; Tshefu AK; Duong TT; Phuc BQ; Laurijssens B; Klopper R; Khim N; Legrand E; Ménard D
    Malar J; 2019 Apr; 18(1):126. PubMed ID: 30967148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda.
    Tumwebaze PK; Conrad MD; Okitwi M; Orena S; Byaruhanga O; Katairo T; Legac J; Garg S; Giesbrecht D; Smith SR; Ceja FG; Nsobya SL; Bailey JA; Cooper RA; Rosenthal PJ
    Nat Commun; 2022 Oct; 13(1):6353. PubMed ID: 36289202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.
    Sonoiki E; Ng CL; Lee MC; Guo D; Zhang YK; Zhou Y; Alley MR; Ahyong V; Sanz LM; Lafuente-Monasterio MJ; Dong C; Schupp PG; Gut J; Legac J; Cooper RA; Gamo FJ; DeRisi J; Freund YR; Fidock DA; Rosenthal PJ
    Nat Commun; 2017 Mar; 8():14574. PubMed ID: 28262680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.